Cost Of False Positive Blood Cultures
As healthcare costs rise, hospitals are under severe pressure to do more with less.
In this environment, reducing costs without compromising care is a top priority for every hospital decision maker.
Treatment resulting from false positive blood cultures is one source of unnecessary resource consumption hospitals can reduce. Significant cost drivers associated with inaccurate septicemia diagnoses include:
Many independent, peer-reviewed studies have demonstrated that the cost of a false positive blood culture can average $3,500 or more. The good news? That’s money you don’t have to spend.
In 2008, Gander et al. conducted a study at Parkland Hospital in Dallas which quantified incremental charges per false positive blood culture patient-instance of $8,720. Using an industry benchmark 40% cost-to-charge ratio, this analysis indicates that hospitals incur incremental unnecessary costs of $3,488 per false positive result. These costs include antibiotic therapies, extended length of stay, and other tests/treatments that are administered based on false positive blood culture results.See the Evidence >